Neuroglee
Singapore, Singapore
Neuroglee discovers, develops and commercializes personalized evidence-based digital therapeutics (DTx) and virtual care solutions to treat and manage patients with neurodegenerative diseases. The company also is breaking new ground by offering first-of-their-kind virtual specialty care clinics for patients diagnosed with mild cognitive impairment related to difficult-to-treat conditions such as Alzheimer's disease. Using several novel digital biomarkers, Neuroglee's adaptive learning platform leverages machine learning to dynamically and continuously personalize and optimize treatment based on patients' unique cognitive and physical needs. By combining best-in-class cognitive rehabilitation strategies and remote care management, Neuroglee can be used independently or in conjunction with pharmacotherapy to help delay or slow the worsening of symptoms in patients with mild cognitive impairment due to Alzheimer's or other neurodegenerative conditions.
Company Info
- Founded
- 2020
- Website
- www.neuroglee.com/
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Neuroglee?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.